Ishii, Akiko

Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders

Yatsuga, S., Fujita, Y., Ishii, A., Fukumoto, Y., Arahata, H., Kakuma, T., Kojima, T., Ito, M., Tanaka, M., Saiki, R., et al. (2015) · Annals of Neurology

GDF15 and Related BiomarkersMitochondrial Function and Pathology

Cited by 293

Nuclear factor (erythroid derived 2)-like 2 activation increases exercise endurance capacity via redox modulation in skeletal muscles

Oh, S., Komine, S., Warabi, E., Akiyama, K., Ishii, A., Ishige, K., Mizokami, Y., Kuga, K., Horie, M., Miwa, Y., et al. (2017) · Scientific Reports

Exercise and Physiological ResponsesGenomics, phytochemicals, and oxidative stress

Cited by 70

Highly Efficient Ultracentrifugation-free Chromatographic Purification of Recombinant AAV Serotype 9

Tomono, T., Hirai, Y., Okada, H., Miyagawa, Y., Adachi, K., Sakamoto, S., Kawano, Y., Chono, H., Mineno, J., Ishii, A., et al. (2018) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchProtein purification and stability

Cited by 55

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates

Ishii, A., Okada, H., Hayashita-Kinoh, H., Shin, J.-H., Tamaoka, A., Okada, T., & Takeda, S. (2020) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research

Cited by 18